To determine the clinical relevance of the BTG3-AKT axis, we performed IHC staining on paraffin-embedded sections of clinical prostate cancer specimens to compare the levels of BTG3 and phospho-AKT (pT308) (Figure 7f). The gene discussed is AKT1; the disease is prostate cancer.